scholarly journals A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement

Author(s):  
Daijiro Harada ◽  
Toshiyuki Kozuki ◽  
Naoyuki Nogami ◽  
Akihiro Bessho ◽  
Shinobu Hosokawa ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document